Riskpilot← Back to searchSign inGet full accessSCANVACC AS
ASActiveOrg 979142943Torjusbakken 16, 0378 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 19973 employees
Revenue 2024
NOK 103K
0% vs 2023
EBITDA margin
-6462.5%
-5% vs 2023
Equity ratio
97.6%
Financial strength
Net profit 2024
NOK -5,9M
-25% vs 2023
| Revenue | NOK 103K | +0% |
| EBITDA | NOK -6,7M | -5% |
| Net profit | NOK -5,9M | -25% |
| Total assets | NOK 41,4M | -13% |
| Equity | NOK 40,4M | -13% |
| Employees | 3 | — |
Legal name
SCANVACC AS
Org number
979142943
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
12. august 1997
Share capital
NOK 160 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Torjusbakken 16, 0378 Oslo
Phone
+4763908990
Email
postmaster@scanvacc.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 61 982 | 58 510 | 3 338 | 3 768 | 4 340 | 4 616 | 5 707 | 8 821 | 10 703 | 11 751 | 10 765 | 10 288 | 10 218 | 1 823 | 59 | 103 | 103 |
| Staff expenses | −0 | −6 880 | −3 383 | −2 541 | −3 511 | −3 791 | −3 732 | −4 377 | −5 058 | −5 104 | −5 541 | −5 520 | −5 753 | −5 793 | −4 928 | −4 150 | −4 629 | −4 977 |
| EBITDA | 0 | 11 316 | 24 043 | −272 | −1 078 | −498 | −504 | 53 | 1 259 | 2 668 | 3 327 | 2 770 | 2 777 | 3 448 | −7 333 | −7 864 | −6 331 | −6 678 |
| Depreciation & amort. | −0 | −78 | −125 | −177 | −307 | −330 | −199 | −200 | −330 | −309 | −180 | −163 | −166 | −121 | −80 | −7 | −13 | −13 |
| EBIT | 0 | 11 239 | 23 918 | −449 | −1 385 | −828 | −703 | −146 | 929 | 2 358 | 3 147 | 2 607 | 2 611 | 3 328 | −7 413 | −7 871 | −6 343 | −6 691 |
| Net financials | 0 | 1 199 | 866 | 2 243 | 4 890 | 1 199 | 4 324 | 15 409 | 37 880 | 28 201 | 17 686 | 30 212 | 158 439 | 613 | 482 | 1 348 | 387 | −446 |
| Profit before tax | 0 | 12 438 | 24 785 | 1 794 | 3 505 | 371 | 3 621 | 15 263 | 38 810 | 30 559 | 20 833 | 32 818 | 161 050 | 3 941 | −6 931 | −6 523 | −5 956 | −7 137 |
| Tax | −0 | 3 205 | 6 944 | 15 | −271 | −155 | −178 | 106 | 288 | 619 | 779 | 598 | 1 801 | 1 090 | −1 479 | −1 582 | −1 222 | −1 233 |
| Net profit | 0 | 9 233 | 17 841 | 1 778 | 3 776 | 527 | 3 799 | 15 156 | 38 522 | 29 940 | 20 054 | 32 220 | 155 081 | 2 851 | −5 452 | −4 941 | −4 734 | −5 904 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | 40 831 | 35 688 | 29 890 | 29 175 | 23 129 | 25 086 | 39 295 | 62 768 | 54 968 | 44 960 | 56 427 | 185 044 | 66 308 | 58 705 | 53 190 | 47 701 | 41 413 |
| Equity | — | 10 160 | 22 601 | 20 579 | 18 555 | 18 082 | 20 631 | 20 787 | 21 309 | 21 249 | 21 303 | 23 524 | 178 605 | 61 456 | 56 004 | 51 062 | 46 328 | 40 424 |
| Long-term debt | 0 | 0 | 4 839 | 4 055 | 3 238 | 2 575 | 1 993 | 1 667 | 1 255 | 977 | 749 | 559 | 426 | 357 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 30 671 | 8 248 | 5 256 | 7 381 | 2 473 | 2 462 | 16 841 | 40 204 | 32 742 | 22 908 | 32 344 | 6 013 | 4 495 | 2 702 | 2 128 | 1 373 | 989 |
| Total debt | 0 | 30 671 | 13 087 | 9 312 | 10 620 | 5 048 | 4 455 | 18 508 | 41 459 | 33 719 | 23 657 | 32 904 | 6 439 | 4 852 | 2 702 | 2 128 | 1 373 | 989 |
EBITDA margin
-6462.5%
This company
15.8%
Market median
-41002% vs market
20072024
Equity ratio
97.6%
This company
38.2%
Market median
+155% vs market
20072024
Return on equity
-14.6%
This company
18.4%
Market median
-179% vs market
20072024
Net profit margin
-5713.4%
This company
8.1%
Market median
-70636% vs market
20072024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20072024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20072024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Chairman | 2014 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Erdal As | Company | 40.0% | 40.0% | 2022 |
Kaurstad As | Company | 40.0% | 40.0% | 2022 |
Kveda As | Company | 20.0% | 20.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Kveda As
SCANVACC AS Board members of SCANVACC AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Andreas Speilberg | Board of Directors | 0 companies |
| Ole Kristian Kaurstad | Chairman | 0 companies |
| Jon Inge Erdal | Chairman | 0 companies |
| Elisabeth Morthen | Board of Directors | 0 companies |